All news from Anaesthesiology

Pain Management and Palliative Care in Ovarian Cancer

A common goal for palliative care is pain management, where opioids like morphine are often on the frontline. Then, practitioners may build on medications from there, adding agents such as gabapentin and tricyclic antidepressants

To add to the message that palliative care should be individualized for each patient, researchers are investigating this even further with a drug, ketamine which is typically used to kickstart and maintain anesthesia used for the difficult-to-treat pain associated with ovarian cancer.

MIT’s In-Body GPS Improve Proton Therapy

Tracking tumors inside the body may become easier with the help of a newly developed “in-body GPS” called Remix from researchers at the Massachusetts Institute of Technology (MIT)’s Computer Science and Artificial Intelligence Laboratory in collaboration with Massachusetts General Hospital. 

Clinical Trials of New Malaria Drug has Began, Researchers

After decades a new drug against malaria has been developed and first clinical trials of this new investigational drug is soon to begin. Enrolment for the same has already started. This study is to be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH). It is to take place at the Duke University School of Medicine in Durham, North Carolina.

Trial To Reduce Major Cause Of Hearing Loss At Birth

Researchers are beginning recruitment in a trial to see if changing pregnant women's hygiene habits could reduce the risks of a major cause of childhood disabilities. Cytomegalovirus, or CMV, is the most common congenital infection in the UK, affecting around 1000 babies every year. If babies are infected while in the womb it can result in serious health problems, such as cerebral palsy, developmental delay and hearing loss.

Approximately one in five babies with congenital CMV will have long-term health problems, which can also include seizures, sight problems, small head size, and intellectual disability. Even babies born with the infection who don't have symptoms at birth are at risk of developing hearing loss later in life.

Susceptible Period For Cardiovascular Complications In Patients Recovering From Sepsis

According to a study, researchers examine the temporal change and susceptible periods for cardiovascular complications in patients recovering from sepsis by using a national database. Patients with sepsis are at increased risk of stroke or myocardial infarction (heart attack) in the first 4 weeks after hospital discharge. The study was published in the CMAJ (Canadian Medical Association Journal).